Zelihagül Değim

Quantum Drugs (Q-Drugs): A New Discovery and Taboo Breaking Approach; Producing Carbon Quantum Dots from Drug Molecules

Gamze Çamlık, Besa Bilakaya, Gökçe Karaotmarlı Güven, Esra Küpeli Akkol et autres

Background/Objectives: Carbon quantum dots (CQDs) are carbon-based structures with particle sizes ranging from 1 to 10 nm. They can be prepared using various carbon sources, including those doped with heteroatoms. CQDs exhibit unique optoelectronic properties, high photostability, low toxicity, and exceptional biocompatibility. …

tr, cl (code pays fourni par la source)

Review of: "[Mini Review] Cytobiological Alterations Induced by Celecoxib as an Anticancer Agent for Breast and Metastatic Breast Cancer"

Zelihagül Değim

tr (code pays fourni par la source)

List of contributors

Ernest Chiedoziam Agwamba, Samad Ahadian, Fatemeh Maghsood Ahmadi, Roohollah Ahmadian et autres

Nigéria, ir, tr, fr, mx, us, de (code pays fourni par la source)

New generation of composite carbon quantum dots for imaging, diagnosing, and treatment of cancer

Gamze Çamlık, Besa Bilakaya, Perihan Uyar, Zelihagül Değim et autres

tr (code pays fourni par la source)

Zeta Potential Determination of Targeted Nanoparticles

Melike Demirbolat, Zelihagül Değim, İsmail Tuncer Değim

In a dispersion system, colloids interact with one another. It is assumed that these interactions are promoted by two main forces, London-van der Waals forces that lead to attraction and electromagnetic effects that leads to repulsion. The zeta potential (ZP) is the …

Formation of quantum water in nanoparticulate systems

Fırat Yerlikaya, Gamze Çamlık, Esra Küpeli Akkol, Zelihagül Değim et autres

tr, es, cl (code pays fourni par la source)

Can Carbon Quantum Dots (CQDs) or Boron Compounds be an Ultimate Solution for COVID-19 Therapy?

Gamze Çamlık, Zelihagül Değim, İsmail Tuncer Değim

family and known to cause similar illnesses in humans. The last outbreak has been identified as a Pandemic because of COVID-19 infections in humans. This review has been prepared to give some information to readers or scientists about some new generation of …

tr (code pays fourni par la source)

Development and validation of highly selective method for the determination of imatinib mesylate and dexketoprofen trometamol combination in three different media

Özlem Çoban, Zelihagül Değim

Imatinib mesylate is a small molecule used in cancer therapy as a thyrosine kinase inhibitor. Dexketoprofen trometamol is a non-steroidal anti-inflammatory drug that has seen use in cancer therapy in combination with an anticancer drug to minimize tumor size and to reduce …

Tamoxifen/raloxifene loaded liposomes for oral treatment of breast cancer

N. Başaran Mutlu Ağardan, Zelihagül Değim, Şükran Yılmaz, Levent Altıntaş et autres

tr (code pays fourni par la source)

Development and validation of highly selective method for the determination of imatinib mesylate and dexketoprofen trometamol combination in three different media

Özlem Çoban, Zelihagül Değim

Imatinib mesylate is a small molecule used in cancer therapy as a thyrosine kinase inhibitor. Dexketoprofen trometamol is a non-steroidal anti-inflammatory drug that has seen use in cancer therapy in combination with an anticancer drug to minimize tumor size and to reduce …

tr (code pays fourni par la source)

Efficacy of targeted liposomes and nanocochleates containing imatinib plus dexketoprofen against fibrosarcoma

Özlem Çoban, Zelihagül Değim, Şükran Yılmaz, Levent Altıntaş et autres

The main challenges in treating cancer using chemotherapeutics are insufficient dose at the target site and the development of drug resistance, while higher doses can induce side effects by damaging nontarget tissues. Combinatorial drug therapy may overcome these limitations by permitting lower …

tr (code pays fourni par la source)

Novel Approach to the Treatment of Diabetes: Embryonic Stem Cell and Insulin-Loaded Liposomes and Nanocochleates

Çiğdem Yücel, Yeşim Altintaş, Zelihagül Değim, Şükran Yılmaz et autres

insulin that releases from the formulations was determined using Franz-type diffusion cells. A cytotoxicity test revealed that none of the formulations was toxic to cells in any concentrations. The effects of the formulations on diabetic cells induced with glucose and streptozotocin (STZ) …

tr (code pays fourni par la source)